ImClone Systems Improves Environmental and Utility Monitoring Efficiency and Accuracy with MODA™
Paper-based processes still burden most QC micro programs with paper scheduling, lab marker labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company committed to advancing oncology care by developing targeted biologic treatments designed to address the medical needs of cancer patients, successfully implemented MODA™—a paperless QC micro solution by Lonza. As a result, ImClone improved the productivity of its QC Analysts, thus reducing the hiring requirements to support the expanded facility – a significant cost savings. ImClone also improved accuracy of the new workflow, giving them a more robust QC operation.
Click here to download the PDF
Subscribe now to Cleanroom Technology to get unrestricted online access to our exclusive content and receive our high quality magazine every month.
|Lonza MODA Solution||company profile|